Filing Details
- Accession Number:
- 0000899243-22-007203
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-22 16:51:08
- Reporting Period:
- 2022-02-17
- Accepted Time:
- 2022-02-22 16:51:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1550395 | David Altshuler | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Global Research And Cso | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-02-17 | 3,439 | $232.51 | 53,999 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2022-02-18 | 986 | $229.22 | 53,013 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-02-18 | 1,303 | $230.05 | 51,710 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-02-18 | 385 | $231.01 | 51,325 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-02-18 | 600 | $231.85 | 50,725 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-02-18 | 1,038 | $233.27 | 49,687 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Mr. Altshuler's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $229.22 (range $228.65 to $229.60).
- Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $230.05 (range $229.65 to $230.59).
- Open market sales reported on this line occurred at a weighted average price of $231.01 (range $230.66 to $231.43).
- Open market sales reported on this line occurred at a weighted average price of $231.85 (range $231.67 to $232.01).
- Open market sales reported on this line occurred at a weighted average price of $233.27 (range $232.91 to $233.50).
Billionaire Hedge Funds
